Source: FinanzNachrichten

Charm Therapeutics: CHARM Therapeutics Bolsters Leadership Team with Key Promotion and Strategic Appointment

CHARM Therapeutics, a 3D deep learning biotechnology company discovering and developing transformational medicines, today announced the promotion of Sarah Skerratt, Ph.D., to Chief Scientific Offi...

Read full article »
Charm Therapeutics's Competitors | Charm Therapeutics's News | Charm Therapeutics's Financials
Stay up-to-date with the latest news on Charm Therapeutics
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Laksh Aithani's photo - CEO of Charm Therapeutics

CEO

Laksh Aithani

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Charm Therapeutics